Christopher W. Fulton

Array ( [id] => 4860292 [patent_doc_number] => 20080269142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'ENDOGENOUS THIADIAZABICYCLO GLUTATHIONE-ADDUCT' [patent_app_type] => utility [patent_app_number] => 11/877650 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7231 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269142.pdf [firstpage_image] =>[orig_patent_app_number] => 11877650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921950 [patent_doc_number] => 20080070265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/875247 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4742 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070265.pdf [firstpage_image] =>[orig_patent_app_number] => 11875247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892968 [patent_doc_number] => 20080102066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'ULTRAPURE TRANSFERRIN FOR PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/875372 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8025 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102066.pdf [firstpage_image] =>[orig_patent_app_number] => 11875372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286230 [patent_doc_number] => 08642559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'C-terminal domain truncation of mGluR1α by calpain and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/443157 [patent_app_country] => US [patent_app_date] => 2007-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 12000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12443157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813836 [patent_doc_number] => 20080194467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 11/863127 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16452 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194467.pdf [firstpage_image] =>[orig_patent_app_number] => 11863127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644572 [patent_doc_number] => 08022178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Modified self-assembling peptides' [patent_app_type] => utility [patent_app_number] => 11/904278 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 43 [patent_no_of_words] => 44203 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022178.pdf [firstpage_image] =>[orig_patent_app_number] => 11904278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288 [patent_doc_number] => 07816327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-19 [patent_title] => 'Inhibition of allergic contact dermatitis by N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester' [patent_app_type] => utility [patent_app_number] => 11/861231 [patent_app_country] => US [patent_app_date] => 2007-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5521 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/816/07816327.pdf [firstpage_image] =>[orig_patent_app_number] => 11861231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7491470 [patent_doc_number] => 08030447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Substrate peptide sequences for plague plasminogen activator and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/901978 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 29 [patent_no_of_words] => 10212 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/030/08030447.pdf [firstpage_image] =>[orig_patent_app_number] => 11901978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922637 [patent_doc_number] => 20080070953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Inhibitors of interleukin-1 beta converting enzyme' [patent_app_type] => utility [patent_app_number] => 11/901843 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56729 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070953.pdf [firstpage_image] =>[orig_patent_app_number] => 11901843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452182 [patent_doc_number] => 20090068219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Anti-wrinkle hormone-type cosmetic composition' [patent_app_type] => utility [patent_app_number] => 11/900179 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7926 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068219.pdf [firstpage_image] =>[orig_patent_app_number] => 11900179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4771419 [patent_doc_number] => 20080057077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'TUMOUR-ASSOCIATED PEPTIDES BINDING TO MHC-MOLECULES' [patent_app_type] => utility [patent_app_number] => 11/848062 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8826 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057077.pdf [firstpage_image] =>[orig_patent_app_number] => 11848062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320345 [patent_doc_number] => 20100113337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR REDUCING INCIDENCE OR RATE OF DEVELOPMENT OF SKIN CANCERS AND RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/438987 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7710 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113337.pdf [firstpage_image] =>[orig_patent_app_number] => 12438987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166082 [patent_doc_number] => 20070287669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Combined Use of Derivatives of GLP-1 Analogs and PPAR Ligands' [patent_app_type] => utility [patent_app_number] => 11/843695 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5372 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287669.pdf [firstpage_image] =>[orig_patent_app_number] => 11843695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355469 [patent_doc_number] => 20090186813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'CHRONIC TREATMENT REGIMEN USING GLUCAGON-LIKE INSULINOTROPIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/836814 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17142 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186813.pdf [firstpage_image] =>[orig_patent_app_number] => 11836814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538776 [patent_doc_number] => 20090220581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHODS OF REDUCING INFLAMMATION AND MUCUS HYPERSECRETION' [patent_app_type] => utility [patent_app_number] => 11/834446 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 46412 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220581.pdf [firstpage_image] =>[orig_patent_app_number] => 11834446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939417 [patent_doc_number] => 20080076736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'COMPOSITIONS CONTAINING LYSOPHOSPHATIDIC ACIDS WHICH INHIBIT APOPTOSIS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/834505 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 40862 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076736.pdf [firstpage_image] =>[orig_patent_app_number] => 11834505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397300 [patent_doc_number] => 20090317363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Cytokine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/309569 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13910 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317363.pdf [firstpage_image] =>[orig_patent_app_number] => 12309569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397300 [patent_doc_number] => 20090317363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Cytokine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/309569 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13910 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317363.pdf [firstpage_image] =>[orig_patent_app_number] => 12309569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397300 [patent_doc_number] => 20090317363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Cytokine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/309569 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13910 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317363.pdf [firstpage_image] =>[orig_patent_app_number] => 12309569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5397300 [patent_doc_number] => 20090317363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Cytokine Derivatives' [patent_app_type] => utility [patent_app_number] => 12/309569 [patent_app_country] => US [patent_app_date] => 2007-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13910 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317363.pdf [firstpage_image] =>[orig_patent_app_number] => 12309569 [rel_patent_id] =>[rel_patent_doc_number] =>)